Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

23 August 2013: Articles  

Compulsive showering and marijuana use – the cannabis hyperemisis syndrome

Fawwaz Mohammed ABCDEF , Kirby Panchoo ABF , Maria Bartholemew ABDF , Dale Maharaj ABCDEFG

DOI: 10.12659/AJCR.884001

Am J Case Rep 2013; 14:326-328

0 Comments

Background

Cannabis (or more affectionately referred to on the street as marijuana or ganja) is one of the most frequently used illicit drugs both internationally [1] and in the Caribbean islands [2,3]. Cannabis has several well known effects on the gastrointestinal system. More recently, and less well recognized, is the cannabinoid hyperemesis syndrome (CHS), which is typified by the tetrad of cyclical vomiting, abdominal pain, compulsive hot showering, and chronic marijuana use [4–6]. The rarity of the condition can lead to a diagnostic dilemma resulting in extensive and expensive investigations with a delay in treatment. We report the first case of CHS in the Caribbean and highlight the need for being aware of this differential in chronic marijuana smokers, particularly for those who have access to high-potency, genetically engineered marijuana.

Case Report

A 26-year-old Caucasian male presented to our center with a 1-week history of severe colicky epigastric pain heralded by significant nausea for 3 weeks. He had approximately 20 episodes of bilious vomiting daily with numerous bouts of retching. He admitted to smoking 4 “joints” or marijuana cigars every day for the last 2 years, and denied alcohol and tobacco use. He had 4 similar episodes over the last 6 months. During these admissions, he was rehydrated and abdominal imaging revealed no abnormalities. His ongoing nausea was relieved by taking hot showers, of which he took up to 15 times per day, sometimes for more than an hour.

His vital signs were within normal limits and he was found to have mild epigastric tenderness with no peritonism. He was admitted for intravenous fluid rehydration and antiemetics.

Blood investigation revealed no abnormalities with his complete blood count and renal and hepatic function. An abdominal computerized tomography (CT) scan revealed no abnormalities. An esophagogastroduodenoscopy and biopsy revealed mild gastritis negative for Helicobacter pylori. His symptoms initially remained refractory to morphine and antiemetics.

Over the ensuing 48 hours, his symptoms improved and he was slowly weaned off medication. He had no access to marijuana.

The diagnosis of CHS was made and he was counseled on abstinence from marijuana. Though he refused to enter a substance abuse program, he remained cannabis-free and on follow-up at 1, 3 and 6 months revealed no recurrence in symptomatology.

Discussion

Marijuana (ganja or weed, as it is commonly known in the Caribbean) is a popular recreational drug. Marijuana is also one of the most frequently used illicit substances in the United States [7]. Despite being an illicit drug in most countries, the beneficial medicinal effects of marijuana have been well documented; specifically as an antiemetic and appetite stimulant for chemotherapy patients [8]. This effect is brought about by tetrahydrocannabinol (THC), which is the major psycho-active ingredient in marijuana, and its action on endogenous cannabinoid receptors CB1 and CB2. CB1 receptors are expressed primarily in the brain and are thought to be responsible for most of the known effects of marijuana use, such as euphoria and appetite stimulation. However, with chronic use and toxicity, patients may experience paradoxical effect due to continuous THC stimulation of cannabinoid receptors, manifested as cyclical hyperemesis. This observation of symptomatology led to the description of cannabinoid hyperemesis syndrome, which is characterized by cyclic vomiting and nausea, chronic marijuana use, and compulsive bathing, first described by Allen et al in GUT 2004 from a case series of 19 patients in Australia [9]. This confirmed an earlier report by Moore et al in 1996 describing a chronic cannabis abuser with psychogenic vomiting, which was complicated by pneumomediastinum [10]. The proposed toxicity noticed with chronic use is attributed to marijuana’s long half-life, fat solubility, delayed gastric emptying, and thermoregulatory and autonomic disequilibrium via the limbic system [9]. This hyperemetic response to marijuana has been previously documented to impair peristalsis in a dose-dependent manner [11,12], delay gastric emptying [12], and a demonstrated response to acute toxicity of intravenous injection of crude marijuana extract [13].

Patients have also exhibited odd behaviour such as compulsive bathing in hot water and autonomic symptoms of sweating, flushing, thirst, abdominal pain, and alterations in body temperature. This behavior is caused by the effect of marijuana on the limbic system of the brain, particularly the hippocampal-hypothalamic-pituitary level [11,14,15]. Compulsive hot water bathing is present in most cases and patients seem to gain relief of symptoms. There are 2 theories for this relief: 1) Chronic CB1 receptor stimulation near the thermoregulatory center of the hypothalamus might be reversed by warm bathing [8] and 2) Redistribution of blood flow from the gut to the skin with warm bathing relieving the CB1 mediated vasodilation of the gut associated with chronic use, the so called “cutaneous steal syndrome” [16]. With the more recent publications on this topic [4,16–18] it has become prudent that physicians have a diagnostic criteria along with a high index of suspicion in treating this syndrome. The diagnostic criteria described by Sontineni et al in 2009 include: 1) history of regular cannabis use for years, 2) severe nausea and vomiting, 3) vomiting that recurs in a cyclic pattern over months, and 4) resolution of symptoms after stopping cannabis use [19]. In addition, there are supportive features in the syndrome such as compulsive hot baths and colicky abdominal pain. This classification was also modified in 2012 after a case series of 98 patients at the Mayo Clinic [4].

Conclusions

Marijuana use is common in the Caribbean region. This is mainly due to its easy accessibility and low cost. Cannabinoid hyperemesis syndrome, although recently described, may be prominent in chronic marijuana users. As a result, physicians need to be aware of its symptomatology and make the diagnosis based on a detailed history and avoiding expensive, invasive surgical treatment, which can be useless and occasionally harmful to the patient.

References:

1.. Schulden JD, Thomas YF, Compton WM, Substance abuse in the United States: findings from recent epidemiologic studies: Curr Psychiatry Rep, 2009; 11(5); 353-59, pmid: 19785975

2.. Maharaj RG, Nunes P, Renwick S, Health risk behaviours among adolescents in the English-speaking Caribbean: a review: Child Adolesc Psychiatry Ment Health, 2009; 3(1); 10, pmid: 19292922

3.. Harvey SC, Patterns of drug abuse in persons referred to the drug rehabilitation unit in Barbados [abstract]: West Indian Med J, 1997; 46; 39

4.. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH, Cannabinoid hyperemesis: a case series of 98 patients: Mayo Clin Proc, 2012; 87(2); 114-19, pmid: 22305024

5.. Wallace EA, Andrews SE, Garmany CL, Jelley MJ, Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm: Sout Med J, 2011; 104(9); 659-64

6.. Pareek N, Fleisher DR, Abell T, Cyclic vomiting syndrome: what a gastroenterologist needs to know: Am J Gastroenterol, 2007; 102(12); 2832-40, pmid: 18042112

7.. Compton WM, Grant BF, Colliver JD, Prevalence of marijuana use disorders in the united states. 1991–1992 and 2001–2002: JAMA, 2004; 291; 2114-21, pmid: 15126440

8.. Sallae SE, Zinberg NE, Frei E, Antiemetic effect of Delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy: N Engl J Med, 1975; 293(16); 795-97, pmid: 1099449

9.. Allen JH, De Moore GM, Heddle R, Twartz JC, Cannabinoid hyperemesis in association with chronic cannabis abuse: Gut, 2004; 53; 1566-70, pmid: 15479672

10.. De Moore GM, Baker J, Bui T, Psychogenic vomiting complicated by marijuana abuse and spontaneous mediastinum: Aust N Z Psychiatry, 1996; 30; 290-94

11.. Pertwee RG, Cannabinoids and the gastrointestinal tract: Gut, 2001; 48; 859-67, pmid: 11358910

12.. McCallum RW, Soykan J, Sridhar KR, Delta-9-tetrahydrocannabinoid delays the gastric emptying of solid food in humans: a double-blind, randomized study: Aliment Pharmacol Ther, 1999; 13; 77-80, pmid: 9892882

13.. Vaziri ND, Thomas R, Sterling M, Toxicity with intravenous injection of crude marijuana extract: Clin Toxicol, 1981; 18; 353-66, pmid: 7237964

14.. Childers SR, Breivogel CS, Cannabis and endogenous cannabinoid systems: Drug Alcohol Depend, 1998; 51; 173-87, pmid: 9716939

15.. Herkenham M, Lynn AB, Little MD, Cannabinoid receptor localization in brain: Proc Natl Acad Sci USA, 1990; 87; 1932-36, pmid: 2308954

16.. Patterson DA, Smith EL, Monahan M, Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation: J Am Board Fam Med, 2010; 23(6); 790-93, pmid: 21057076

17.. Price SL, Fisher C, Kumar R, Hilgerson A, Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting: J Am Osteopath Assoc, 2011; 111(3); 166-69, pmid: 21464265

18.. Soriano-Co M, Batke M, Cappell MS, The Cannabis Hyperemesis Syndrome characterized by persistent nausea and vomiting,abdominal pain and compulsive bathing associated with chronic marijuana use: A report of eight cases in United State: Dig Dis Sci, 2010; 55; 3113-19, pmid: 20130993

19.. Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ, Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse: World J Gastroenterol, 2009; 15(10); 1264-66, pmid: 19291829

In Press

Case report  China

Thrombolytic Therapy After Return of Spontaneous Circulation in Patients With STEMI From Medically Underdev...

Am J Case Rep In Press; DOI: 10.12659/AJCR.949976  

Case report  Greece

Multilevel Laminectomy for Lumbar Spinal Stenosis With Low Back Pain in Achondroplasia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950290  

Case report  Italy

Fractional CO₂ Laser (SCAR3 Scanner) for a Hypertrophic Retracting Cleft Lip Scar: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950607  

Case report  Saudi Arabia

Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950985  

Most Viewed Current Articles

07 Dec 2021 : Case report  USA 17,691,734

Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Fac...

DOI :10.12659/AJCR.934347

Am J Case Rep 2021; 22:e934347

06 Dec 2021 : Case report  Brazil 164,491

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

21 Jun 2024 : Case report  China (mainland) 113,090

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

DOI :10.12659/AJCR.944371

Am J Case Rep 2024; 25:e944371

0:00

07 Mar 2024 : Case report  USA 59,175

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923